Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Rosso Felipe

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Transplantation Research|June 14, 2016
Reviewing 15 years of experience with sirolimusHelio Tedesco Silva, Claudia Rosso Felipe, Jose Osmar Medina Pestana
Transplantation|May 11, 2016
Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A ReappraisalCarla C Baan, Nynke M Kannegieter, Claudia Rosso Felipe, et al.
Drugs|September 19, 2006
Immunotherapy for De Novo renal transplantation: what's in the pipeline?Helio Tedesco Silva, Paula Pinheiro Machado, Claudia Rosso Felipe, et al.
Pharmacotherapy|January 23, 2016
Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus RegimensMaria Julia Pereira Felix, Claudia Rosso Felipe, Hélio Tedesco-Silva, et al.
Therapeutic Drug Monitoring|November 8, 2012
Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimusHelio Tedesco-Silva, Claudia Rosso Felipe, Alan Slade, et al.
Clinical and Experimental Nephrology|December 13, 2025
Effects of dialysis therapies on circulating levels of endothelial markers after kidney transplant in children: focus on positive aspect of peritoneal dialysisGiovanna Assoni Rodrigues, Fernanda Thomazini, Claudia Rosso Felipe, et al.
Journal of Developmental Origins of Health and Disease|August 17, 2019
Is low birth weight an additional risk factor for hypertension in paediatric patients after kidney transplantation?Larissa Badim Santos, Luana Meireles Borges, Livia Victorino Souza, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2003
Time-dependent changes in cyclosporine exposure: implications for achieving target concentrationsClaudia Rosso Felipe, Helio Tedesco Silva, Paula Goulart Pinheiro Machado, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 20, 2016
Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantationCahue Henrique Pinto, Helio Tedesco-Silva, Claudia Rosso Felipe, et al.
Jornal Brasileiro De Nefrologia|January 8, 2025
Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft lossAdrieli Barros Bessa, Marina Pontello Cristelli, Claudia Rosso Felipe, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Transplantation Research|June 14, 2016
Reviewing 15 years of experience with sirolimusHelio Tedesco Silva, Claudia Rosso Felipe, Jose Osmar Medina Pestana
Transplantation|May 11, 2016
Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A ReappraisalCarla C Baan, Nynke M Kannegieter, Claudia Rosso Felipe, et al.
Drugs|September 19, 2006
Immunotherapy for De Novo renal transplantation: what's in the pipeline?Helio Tedesco Silva, Paula Pinheiro Machado, Claudia Rosso Felipe, et al.
Pharmacotherapy|January 23, 2016
Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus RegimensMaria Julia Pereira Felix, Claudia Rosso Felipe, Hélio Tedesco-Silva, et al.
Therapeutic Drug Monitoring|November 8, 2012
Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimusHelio Tedesco-Silva, Claudia Rosso Felipe, Alan Slade, et al.
Clinical and Experimental Nephrology|December 13, 2025
Effects of dialysis therapies on circulating levels of endothelial markers after kidney transplant in children: focus on positive aspect of peritoneal dialysisGiovanna Assoni Rodrigues, Fernanda Thomazini, Claudia Rosso Felipe, et al.
Journal of Developmental Origins of Health and Disease|August 17, 2019
Is low birth weight an additional risk factor for hypertension in paediatric patients after kidney transplantation?Larissa Badim Santos, Luana Meireles Borges, Livia Victorino Souza, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2003
Time-dependent changes in cyclosporine exposure: implications for achieving target concentrationsClaudia Rosso Felipe, Helio Tedesco Silva, Paula Goulart Pinheiro Machado, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 20, 2016
Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantationCahue Henrique Pinto, Helio Tedesco-Silva, Claudia Rosso Felipe, et al.
Jornal Brasileiro De Nefrologia|January 8, 2025
Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft lossAdrieli Barros Bessa, Marina Pontello Cristelli, Claudia Rosso Felipe, et al.
Pageof 4